AVP and pancreatic neoplasm: Panni et al. utilized a novel strategy by using a partial activator of CD11b, ADH-503 that increases CD11-dependent cell adhesions on the endothelium to prevent subsequent tissue extravasation and found that ADH-503 effectively reduces the number of tumor-infiltrating myeloid cells in murine pancreatic cancer [119].